MindMed: Not The Horse To Back If You're Looking To Buy Psychedelics (NASDAQ:MNMD)
seekingalpha.com
news
2022-10-19 19:27:47

RapidEye/E+ via Getty Images Investment Overview I last covered MindMed (NASDAQ:MNMD), a company developing "pharmaceutically optimized drug products derived from the psychedelic and empathogen drug classes", for Seeking Alpha back in July. In my last note, I discussed some of the difficulties facing drug developers working with psychedelic drugs - which include, besides MindMed, listed companies such as Compass Pathways (CMPS), Bright Minds Biosciences (DRUG), Atai Life Sciences (ATAI), Cybin Inc.
